Literature DB >> 30575893

MEG3 damages fetal endothelial function induced by gestational diabetes mellitus via AKT pathway.

H-H Ye1, S-H Yang, Y Zhang.   

Abstract

OBJECTIVE: To explore the role of maternally-expressed gene 3 (MEG3) in fetal endothelial dysfunction induced by gestational diabetes mellitus (GDM) and its underlying mechanism. PATIENTS AND METHODS: Human umbilical vein endothelial cells (HUVECs) were extracted from GDM pregnancies and normal pregnancies. Cell proliferation, apoptosis, migration and angiogenesis of HUVECs were detected by cell counting kit-8 (CCK-8), enzyme-linked immunosorbent assay (ELISA), wound healing and tube formation assay, respectively. MEG3 expressions in HUVECs extracted from 16 GDM pregnancies and 18 normal pregnancies were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Besides, angiogenesis and MEG3 expression in HUVECs treated with glucose were detected, respectively. Proliferation, apoptosis, migration and angiogenesis were also detected after HUVECs were transfected with MEG3 lentivirus. Target genes of MEG3 were predicted by bioinformatics method and further verified by luciferase reporter gene assay. The protein expression of possible signaling pathway was detected by Western blot.
RESULTS: HUVEC cells extracted from GDM pregnancies presented increased apoptosis and decreased proliferation, migration and angiogenesis compared with those from healthy pregnancies. Meanwhile, MEG3 was overexpressed in HUVECs extracted from GDM pregnancies compared with that of healthy pregnancies. High dose of glucose treatment led to reduced angiogenesis and elevated MEG3 expression in HUVECs. MEG3 overexpression further promoted apoptosis, but inhibited proliferation, migration and angiogenesis of HUVECs. By bioinformatics and luciferase reporter gene assay, microRNA-370-3p was found to be the target gene of MEG3 and directly targeted on AFF1. Moreover, MEG3 overexpression led to downregulated microRNA-370-3p and upregulated AFF1 mainly through inhibiting PI3K/AKT pathway.
CONCLUSIONS: MEG3 is overexpressed in HUVECs extracted from GDM pregnancies. MEG3 damages fetal endothelial function through targeting microRNA-370-3p and AFF1 via PI3K/AKT pathway.

Entities:  

Year:  2018        PMID: 30575893     DOI: 10.26355/eurrev_201812_16617

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

1.  Profiling and functional analysis of differentially expressed circular RNAs in high glucose-induced human umbilical vein endothelial cells.

Authors:  Guoxi Jin; Qiong Wang; Xiaolei Hu; Xiaoli Li; Xiaoyan Pei; Erqin Xu; Minglong Li
Journal:  FEBS Open Bio       Date:  2019-08-22       Impact factor: 2.693

2.  The role of circular RNA circ_0008285 in gestational diabetes mellitus by regulating the biological functions of trophoblasts.

Authors:  Haitian Chen; Shaofeng Zhang; Yanxin Wu; Zhuyu Li; Dongyu Wang; Shiqin Cai; Zilian Wang
Journal:  Biol Res       Date:  2021-04-20       Impact factor: 5.612

3.  lncRNA SNHG17 is Downregulated in Gestational Diabetes Mellitus (GDM) and Has Predictive Values.

Authors:  Jingjun Li; Baoshun Du; Xiuqin Geng; Lin Zhou
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-23       Impact factor: 3.168

4.  Maternally expressed gene 3 regulates retinal neovascularization in retinopathy of prematurity.

Authors:  Yu Di; Yue Wang; Yue-Xia Wang; Xue Wang; Yuan Ma; Qing-Zhu Nie
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

5.  Biological networks in gestational diabetes mellitus: insights into the mechanism of crosstalk between long non-coding RNA and N6-methyladenine modification.

Authors:  Runyu Du; Yu Bai; Ling Li
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-03       Impact factor: 3.105

6.  LncRNA XIST serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell via miR-497-5p/FOXO1 axis.

Authors:  Yanchuan Li; Xiaohua Yuan; Ziyun Shi; Haili Wang; Duomei Ren; Ya Zhang; Yangyang Fan; Yanfeng Liu; Zhangxia Cui
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 7.  Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets.

Authors:  B Alipoor; S Nikouei; F Rezaeinejad; S-N Malakooti-Dehkordi; Z Sabati; H Ghasemi
Journal:  J Endocrinol Invest       Date:  2021-04-01       Impact factor: 4.256

Review 8.  Non-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications.

Authors:  Tiziana Filardi; Giuseppina Catanzaro; Stefania Mardente; Alessandra Zicari; Carmela Santangelo; Andrea Lenzi; Susanna Morano; Elisabetta Ferretti
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

Review 9.  Non-Coding RNAs and Extracellular Vehicles: Their Role in the Pathogenesis of Gestational Diabetes Mellitus.

Authors:  Tie-Ning Zhang; Wei Wang; Xin-Mei Huang; Shan-Yan Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-20       Impact factor: 5.555

Review 10.  Endothelial Dysfunction in Pregnancy Complications.

Authors:  Jakub Kornacki; Paweł Gutaj; Anastasia Kalantarova; Rafał Sibiak; Maurycy Jankowski; Ewa Wender-Ozegowska
Journal:  Biomedicines       Date:  2021-11-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.